InnoCentive, Inc. Release: Two InnoCentive Solvers Win $40,000 for Devising New Methods to Cost-Effectively Manufacture Tuberculosis Drug Candidate
12/4/2008 10:27:57 AM
More...
|
Dr. Mel Spigelman, Director of Synergy Pharmaceuticals, Appointed President and CEO of Global Alliance For TB Drug Development
10/15/2008 9:18:58 AM
More...
|
Global Alliance For TB Drug Development Receives Pledge of up to $40 Million from USAID
10/13/2008 10:46:21 AM
More...
|
Global Alliance For TB Drug Development Appoints First Chief Administrative Officer
8/27/2008 9:12:09 AM
More...
|
Novartis Institute For Tropical Diseases (NVS) and Global Alliance For TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D
6/24/2008 9:23:23 AM
More...
|
Global Alliance For TB Drug Development Appoints Veteran Pharmaceutical Executive as New Chief Executive
3/5/2008 8:46:19 AM
More...
|
GlaxoSmithKline (GSK) and Global Alliance For TB Drug Development Renew Tuberculosis Drug Discovery Program
1/24/2008 8:27:54 AM
More...
|
Cumbre Pharmaceuticals And Global Alliance For TB Drug Development Announce Partnership To Develop New Agents For Tuberculosis Therapy
9/27/2006 10:47:14 AM
More...
|
Gates Foundation Commits $104 Million To Global Alliance For TB Drug Development To Develop Faster Cure For Tuberculosis
5/25/2006 10:19:35 AM
More...
|
Co-Author Of Article In The Lancet Medical Journal Says TB Drug Pipeline Shows Major Progress And Offers Real Hope
3/15/2006 2:14:59 PM
More...
|
|